01 1Bajaj healthcare Ltd
02 1Cadila Pharmaceuticals Limited
03 1Medichem S.A.
01 1Chlorhexidine
02 2Chlorhexidine Base
01 2India
02 1Spain
NDC Package Code : 84855-002
Start Marketing Date : 2024-12-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (500kg/500kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65691-0027
Start Marketing Date : 2006-01-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53296-0010
Start Marketing Date : 2010-06-02
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (75kg/75kg)
Marketing Category : BULK INGREDIENT
38
PharmaCompass offers a list of Chlorhexidine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Chlorhexidine manufacturer or Chlorhexidine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Chlorhexidine manufacturer or Chlorhexidine supplier.
PharmaCompass also assists you with knowing the Chlorhexidine API Price utilized in the formulation of products. Chlorhexidine API Price is not always fixed or binding as the Chlorhexidine Price is obtained through a variety of data sources. The Chlorhexidine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A N',N'''''-hexane-1,6-diylbis[N-(4-chlorophenyl)(imidodicarbonimidic diamide)] manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of N',N'''''-hexane-1,6-diylbis[N-(4-chlorophenyl)(imidodicarbonimidic diamide)], including repackagers and relabelers. The FDA regulates N',N'''''-hexane-1,6-diylbis[N-(4-chlorophenyl)(imidodicarbonimidic diamide)] manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. N',N'''''-hexane-1,6-diylbis[N-(4-chlorophenyl)(imidodicarbonimidic diamide)] API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of N',N'''''-hexane-1,6-diylbis[N-(4-chlorophenyl)(imidodicarbonimidic diamide)] manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A N',N'''''-hexane-1,6-diylbis[N-(4-chlorophenyl)(imidodicarbonimidic diamide)] supplier is an individual or a company that provides N',N'''''-hexane-1,6-diylbis[N-(4-chlorophenyl)(imidodicarbonimidic diamide)] active pharmaceutical ingredient (API) or N',N'''''-hexane-1,6-diylbis[N-(4-chlorophenyl)(imidodicarbonimidic diamide)] finished formulations upon request. The N',N'''''-hexane-1,6-diylbis[N-(4-chlorophenyl)(imidodicarbonimidic diamide)] suppliers may include N',N'''''-hexane-1,6-diylbis[N-(4-chlorophenyl)(imidodicarbonimidic diamide)] API manufacturers, exporters, distributors and traders.
click here to find a list of N',N'''''-hexane-1,6-diylbis[N-(4-chlorophenyl)(imidodicarbonimidic diamide)] suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing N',N'''''-hexane-1,6-diylbis[N-(4-chlorophenyl)(imidodicarbonimidic diamide)] as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for N',N'''''-hexane-1,6-diylbis[N-(4-chlorophenyl)(imidodicarbonimidic diamide)] API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture N',N'''''-hexane-1,6-diylbis[N-(4-chlorophenyl)(imidodicarbonimidic diamide)] as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain N',N'''''-hexane-1,6-diylbis[N-(4-chlorophenyl)(imidodicarbonimidic diamide)] and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a N',N'''''-hexane-1,6-diylbis[N-(4-chlorophenyl)(imidodicarbonimidic diamide)] NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of N',N'''''-hexane-1,6-diylbis[N-(4-chlorophenyl)(imidodicarbonimidic diamide)] suppliers with NDC on PharmaCompass.
We have 3 companies offering N',N'''''-hexane-1,6-diylbis[N-(4-chlorophenyl)(imidodicarbonimidic diamide)]
Get in contact with the supplier of your choice:
